Nexsen Limited
Research Nexsen Limited (NXN.AX) on Bullrun: market cap AUD 28.28M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNXN.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryBiotechnology
- CurrencyAUD
- Market capAUD 28.28M
- Financial periodFY2026
- Net income-AUD 6.55M
Valuation Snapshot
latest market cap is AUD 28.28M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | n/a | -AUD 6.55M | n/a | n/a | -0.04 | AUD 4.49M | AUD 11.61K | AUD 5.66M |
| FY2025 | n/a | n/a | n/a | n/a | -0.03 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 28.28M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Nexsen Limited
Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for human health, food and animal health, and biosecurity applications. The company offers Group B Streptococcus (GBS) rapid sensor; StrepSure, a diagnostic for the detection of human GBS in expectant mothers;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Nexsen Limited's market cap?
Nexsen Limited's market capitalization is AUD 28.28M.
What does Nexsen Limited do?
Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for human health, food and animal health, and biosecurity applications.